Sinopharm Group Co. Ltd. (FRA:X2S)
1.991
-0.010 (-0.50%)
At close: Sep 26, 2025
Sinopharm Group Market Cap
Sinopharm Group has a market cap or net worth of €6.27 billion as of September 30, 2025. Its market cap has increased by 5.20% in one year.
Market Cap
6.27B
Enterprise Value
17.70B
Revenue
68.44B
Ranking
n/a
PE Ratio
7.74
Stock Price
€1.99
Market Cap Chart
Since September 23, 2009, Sinopharm Group's market cap has increased from 3.53B to 6.27B, an increase of 77.57%. That is a compound annual growth rate of 3.65%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 30, 2025 | 6.27B | -24.15% |
Dec 31, 2024 | 8.27B | 11.84% |
Dec 29, 2023 | 7.39B | -0.53% |
Dec 30, 2022 | 7.43B | 24.49% |
Dec 31, 2021 | 5.97B | -3.83% |
Dec 31, 2020 | 6.21B | -35.75% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 262.21B |
Siemens Aktiengesellschaft | 177.42B |
Deutsche Telekom AG | 136.77B |
Allianz SE | 136.28B |
Rheinmetall AG | 89.95B |
Siemens Energy AG | 84.11B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.76B |
Deutsche Bank Aktiengesellschaft | 58.48B |